证券之星消息，8月4日个护用品板块较上一交易日上涨1.67%，倍加洁领涨。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。个护用品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603059 | 倍加洁 | 37.16 | 10.01% | 2.01万 | 7476.70万 | | 605009 | 豪悦护理 | 39.79 | 4.68% | 5.23万 | 2.05亿 | | 001206 | 依依股份 | 25.46 | 3.88% | 5.17万 | 1.30亿 | | 301009 | 可靠股份 | 13.83 | 2.83% | 7.36万 | 1.00亿 | | 600249 | 两面针 | 5.93 | 2.07% | 21.04万 | 1.25亿 | | 603193 | 润本股份 | 33.52 | 1.58% | 13.02万 | 4.40亿 | | 301108 | 洁雅股份 | 26.31 | 1 ...

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Views - The report highlights the strong performance of domestic brands in the skincare and cosmetics sectors on platforms like Douyin, with significant market share gains [5][25][28] - The report emphasizes the importance of emotional consumption trends driving growth in various retail segments, particularly in jewelry, cosmetics, and offline retail [30][31] Summary by Sections Retail Market Overview - The retail industry index decreased by 2.22% during the week of July 28 to August 1, 2025, underperforming the Shanghai Composite Index by 1.28 percentage points [7][14] - The professional chain segment showed the largest increase among retail sub-sectors, while the jewelry sector led the year-to-date performance with a 25.38% increase [17][20] Key Industry Dynamics - In July, Douyin's skincare brand Han Shu ranked first, with domestic brands occupying 15 out of the top 20 spots in the skincare category [25][28] - The cosmetics sector also saw domestic brands excel, with 19 out of the top 20 positions in the makeup category, driven by cushion products and other high-demand items [28][29] Investment Recommendations - Investment focus areas include: - **Jewelry**: Recommend brands with differentiated product offerings like Laopuhuang and Chaohongji [30][33] - **Offline Retail**: Highlight companies like Yonghui Supermarket and Aiyingshi that are adapting to consumer trends [30][31] - **Cosmetics**: Emphasize domestic brands with strong market positions such as Maogeping and Pola [31][32] - **Medical Aesthetics**: Focus on companies with unique product lines like Aimeike and Kedi-B [31][32] Company-Specific Insights - **Laopuhuang**: Achieved revenue of 8.506 billion yuan (+167.5%) and a net profit of 1.473 billion yuan (+253.9%) in FY2024, with strong growth expected in H1 2025 [32] - **Yonghui Supermarket**: Reported a revenue of 17.479 billion yuan (-19.3%) and a net profit of 148 million yuan (-80.0%) in Q1 2025, with ongoing transformation efforts [32] - **Maogeping**: Recorded a revenue of 3.885 billion yuan (+34.6%) and a net profit of 881 million yuan (+33.0%) in FY2024, indicating strong brand momentum [32]

Group 1 - The largest increase in margin financing balance this week was observed in Runben Co., with a margin balance of 326 million yuan, reflecting an increase of 147.62% [1] - Songjing Co. also saw significant growth in its margin financing balance, reaching 125 million yuan, with an increase of 103.81% [1]

Investment Rating - The report suggests a positive outlook for domestic brands and a recovery for international beauty brands in the Chinese market, indicating potential investment opportunities in the cosmetics and medical beauty sectors [2][3]. Core Insights - The cosmetics and medical beauty sector underperformed the market, with the Shenwan Beauty Care Index declining by 3.3% from July 25 to August 1, 2025, while the Shenwan Cosmetics Index fell by 2.6% [3][4]. - Domestic brands showed strong growth during the off-season, with notable increases such as Han Shu up 58%, Proya up 23%, Marubi up 72%, and Kefu Mei up 28%, indicating resilience in the market [7][17]. - International beauty brands, represented by L'Oréal, are recovering in the Chinese market, with a 3% growth in Q2 2025, supported by promotional events like the 618 shopping festival [7][24]. - The report highlights the success of Lin Qingxuan, a high-end domestic skincare brand, which saw revenue grow from 690 million yuan in 2022 to 1.21 billion yuan in 2024, showcasing the potential of domestic brands [13][14]. Summary by Sections Industry Performance - The beauty and medical aesthetics sector has shown weaker performance compared to the overall market, with specific indices declining [3][4]. - The report notes that the cosmetics market is transitioning from quantity to quality, with a significant increase in e-commerce sales, which accounted for 47% of cosmetics sales in 2024, up from 22% in 2016 [9][30]. Key Company Highlights - L'Oréal's sales in China for H1 2025 reached approximately 186.19 billion yuan, with a 3% year-on-year increase, indicating a recovery in the Chinese market [24]. - Procter & Gamble reported a record net sales of approximately 604.95 billion yuan for the 2025 fiscal year, with the beauty segment achieving a net sales of approximately 107.66 billion yuan, reflecting a 2% growth [25]. - Lin Qingxuan's product matrix includes 188 SKUs, with a focus on high-quality natural ingredients, and it has established a strong supply chain and distribution network [14][16]. Market Trends - The report emphasizes the growing market for high-end skincare products, with the market size expected to increase from 749 billion yuan in 2019 to 1,144 billion yuan by 2024, indicating a compound annual growth rate (CAGR) of 13.8% [14][15]. - The domestic brands are gaining market share, with the top ten brands in the skincare market now evenly split between domestic and international brands, reflecting a shift in consumer preferences [30][31].

Market Overview - The personal care products sector increased by 0.68% on August 1, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 3559.95, down 0.37%, while the Shenzhen Component Index closed at 10991.32, down 0.17% [1] Stock Performance - Beijia (603059) closed at 33.78, up 10.00% with a trading volume of 22,200 lots and a transaction value exceeding 74.98 million yuan [1] - Runben Co. (603193) closed at 33.00, up 3.48% with a trading volume of 126,400 lots and a transaction value of 414 million yuan [1] - Yanjing Co. (300658) closed at 6.96, up 2.65% with a trading volume of 240,700 lots and a transaction value of 167 million yuan [1] - Other notable stocks include Nobon Co. (603238) at 17.51 (+2.46%), Ziya Co. (003006) at 25.95 (+1.57%), and Liangmian Needle (600249) at 5.81 (+1.22%) [1] Capital Flow - The personal care products sector saw a net inflow of 8.97 million yuan from institutional investors, while retail investors contributed a net inflow of 18.89 million yuan [2] - However, there was a net outflow of 27.85 million yuan from speculative funds [2] Detailed Capital Flow Analysis - Runben Co. had a net inflow of 60.92 million yuan from institutional investors, but a net outflow of 28.99 million yuan from speculative funds [3] - Beijia experienced a net inflow of 12.06 million yuan from institutional investors, with a net outflow of 10.82 million yuan from speculative funds [3] - Nobon Co. had a net inflow of 1.84 million yuan from retail investors despite a net outflow from institutional and speculative funds [3] - Liangmian Needle saw a net inflow of 0.80 million yuan from retail investors, while experiencing a net outflow from institutional and speculative funds [3]

天眼查商业履历信息显示，润本生物技术股份有限公司，成立于2013年，位于广州市，是一家以从事化 学原料和化学制品制造业为主的企业。企业注册资本40459.3314万人民币，实缴资本40459.3314万人民 币。公司法定代表人为赵贵钦。 金融界消息 截至2025年7月31日收盘，润本股份（603193）报收于31.89元，下跌4.35%，换手率 12.87%，成交量13.30万手，成交金额4.33亿元。 资金流向方面，今日主力资金净流出5789.45万元，占比成交额13.38%。其中，超大单净流出2428.44万 元、占成交额5.61%，大单净流出3361.01万元、占成交额7.77%，中单净流出流出1587.37万元、占成交 额3.67%，小单净流入7376.82万元、占成交额17.05%。 润本股份最新一期业绩显示，截至2025一季报，公司营业总收入2.40亿元、同比增长44.00%，归属净利 润4419.74万元，同比增长24.60%，扣非净利润3861.65万元，同比增长22.85%，流动比率9.710、速动比 率8.639、资产负债率7.69%。 通过天眼查大数据分析，润本生物技术股份有限公司共对外 ...

证券之星消息，7月31日个护用品板块较上一交易日下跌1.99%，延江股份领跌。当日上证指数报收于 3573.21，下跌1.18%。深证成指报收于11009.77，下跌1.73%。个护用品板块个股涨跌见下表： 从资金流向上来看，当日个护用品板块主力资金净流出1.63亿元，游资资金净流出4671.12万元，散户资 金净流入2.1亿元。个护用品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603059 | 倍加洁 | 2786.97万 | 9.56% | -2061.97万 | -7.07% | -725.00万 | -2.49% | | 001328 | 登康口腔 | 783.69万 | 6.75% | -633.61万 | -5.46% | -150.08万 | -1.29% | | 003006 自亚股份 | | 85.10万 | 0.53% | -742.19万 | -4.66% | ...

Core Viewpoint - Runben Biotechnology Co., Ltd. has shown significant revenue growth in its latest quarterly report, indicating a positive financial trajectory despite a recent decline in stock price [1]. Financial Performance - As of the first quarter of 2025, the company reported total revenue of 240 million yuan, representing a year-on-year increase of 44% [1]. - The net profit attributable to shareholders was 44.2 million yuan, up 24.6% year-on-year [1]. - The company's non-recurring net profit reached 38.6 million yuan, reflecting a growth of 22.85% compared to the previous year [1]. - Key financial ratios include a current ratio of 9.71, a quick ratio of 8.639, and a debt-to-asset ratio of 7.69% [1]. Stock Performance - As of July 30, 2025, the stock price closed at 33.34 yuan, down 3.22% [1]. - The trading volume was 133,200 hands, with a total transaction amount of 448 million yuan [1]. - The net inflow of main funds was 14.7 million yuan, accounting for 3.29% of the transaction amount [1]. Company Overview - Runben Biotechnology was established in 2013 and is based in Guangzhou, primarily engaged in the manufacturing of chemical raw materials and products [1]. - The company has a registered capital of 4.0459 billion yuan, with the same amount paid in [1]. - The legal representative of the company is Zhao Guiqin [1]. Investment and Intellectual Property - The company has made investments in 8 enterprises and participated in 13 bidding projects [2]. - It holds 106 trademark registrations and 109 patents, along with 64 administrative licenses [2].

Group 1 - The stock price of Runben Co., Ltd. experienced fluctuations on July 29, closing at 34.45 yuan, down 4.04% from the previous trading day [1] - The stock reached a high of 36.55 yuan and a low of 34.00 yuan during the day, with a volatility of 7.10% [1] - The trading volume was 199,600 hands, with a transaction amount of 696 million yuan [1] Group 2 - Runben Co., Ltd. operates in the beauty and personal care industry, focusing on the research, production, and sales of cosmetics [1] - The company's product range includes personal care and maternal and infant care, with several well-known brands under its umbrella [1] - As a significant cosmetics enterprise in Guangdong, Runben Co., Ltd. has also made strides in the C2M model and new retail sectors [1] Group 3 - On July 29, the stock price of Runben Co., Ltd. showed rapid fluctuations, with a quick drop of over 2% within 5 minutes around 9:35 AM and a rebound of over 2% around 1:57 PM [1] - The net outflow of main funds was 54.7957 million yuan, accounting for 1.54% of the circulating market value, indicating some market divergence [1]

Core Viewpoint - The national childcare subsidy policy will provide an annual subsidy of 3600 yuan per child until the age of three, benefiting over 20 million families each year starting from January 1, 2025 [4][5]. Subsidy Standard - Each child will receive a subsidy of 3600 yuan per year until they turn three years old. For children born before January 1, 2025, who are under three years old, the subsidy will be calculated based on the remaining months [8]. Coverage - The policy applies to all families with children under three years old, regardless of whether they have one, two, or three children, and is uniformly implemented across the country [9]. Application Process - Parents or guardians can apply for the subsidy online through the childcare subsidy information management system or offline, providing necessary documents such as birth certificates and household registration books [10]. Funding Source - The central government will establish a "childcare subsidy fund," providing financial support to eastern, central, and western regions proportionally, with any additional local funding being the responsibility of local governments [11]. Market Impact Analysis - The infant food market is expected to exceed 72 billion yuan, directly benefiting the maternal and infant consumption industry chain [12]. - The childcare industry is projected to reach a scale of 162.1 billion yuan by 2025, with an average annual growth rate of 7.5%, accelerated by the policy [13]. - Demand for children's medical and nutritional health products is anticipated to rise, with the pediatric medication market expected to grow at a rate exceeding 10% annually [14]. Beneficiary Companies - Leading maternal and infant retail companies are expected to benefit directly from increased customer spending and frequency of purchases [15]. - Companies such as Kidswant and Huaiying Room are positioned to gain from the subsidy implementation due to their extensive retail networks and service offerings [16]. - Major players in the infant formula market, like China Feihe and Yili, are likely to see increased demand driven by the subsidy [17][18].